Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Recruiting
N/A
Interventional Study
Peripheral Arterial Disease (PAD)
Amputation
Thrombosis
Thrombosis (Stent Thrombosis)
Platelet Aggregation Inhibitors
Thromboelastography (TEG)
PRU(Platelet Reactivity Unit)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 484 (estimated)
- Sponsor
- Massachusetts General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery disease (PAD) who have undergone a procedure to restore blood flow to their legs.
The main questions it aims to answer are:
* Does the personalized plan lower the rate of blood clots in the treated leg one year after the proc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with a named arterial extremity injury or named vessel revascularization for atherosclerosis requiring open and/or closed revascularization.
* Patients at the age of 18 or older
Exclusion Criteria:
* Patients who are younger than 18 years old
* Known pregnancy (fema…
Contacts